The Small-Cell Lung Cancer market reached a value of USD 8.9 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 23.0 Billion by 2035, exhibiting a growth rate (CAGR) of 9.17% ...

The treatment landscape for HER2-positive NSCLC is rapidly evolving as research continues to reveal the genetic drivers of these tumors. Emerging therapies like Pyrotinib (Jiangsu HengRui Medicine), ...

The global lung cancer surgery market is poised for transformative growth from 2025 to 2035, driven by the increasing ...

John Ryan, a U.S. Navy veteran, beat cancer through nearly a decade of experimental immunotherapy treatment. The vet shared ...

A new artificial intelligence model has demonstrated high accuracy in detecting and outlining lung tumors on CT scans, ...

Columbus Regional Health has the ability to screen for lung cancer and identify it in early stages. Timely identification and diagnosis of lung cancer is the key to long-term survival. Sometimes, ...

Some doctors call DIPNECH a pre cancer. The abnormal cells are all contained within the lining of the lung and have not spread. The stage of a lung neuroendocrine cancer tells you its size and whether ...

Lung cancer survival rates can be as high as 98% for certain cancers diagnosed in an early stage, and as low as 4% for those diagnosed with more aggressive cancers in advanced stages. Survival rates ...

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer ... For NSCLC, radiation can be used in one of four ways: adjuvant therapy (treating remaining cancer cells post-surgery), ...

“Lung cancer does not have any symptoms in its early stages. By the time symptoms appear, it has progressed to Stage 3 or 4 ...

The results of this study show that smaller tumor size at diagnosis is associated with improved curability for patients with stage I non-small cell lung cancers. Disease-specific cure rates for ...